Brief: China Pioneer Pharma Says U.S. FDA Started With Pre-Emergency Use Authorization Process On Coronavirus Test Kit

Shanghai Pioneer Holding

03/06/2020 23:59

June 4 (Reuters) - China Pioneer Pharma Holdings Ltd
 1345.HK :
    * US FDA STARTED WITH PRE-EMERGENCY USE AUTHORIZATION
PROCESS ON
NOVEL CORONAVIRUS IGG/IGM COMBINED ANTIBODY TEST KIT
    * CO ACTS AS EXCLUSIVE AGENT IN US OF VARIOUS NOVEL
CORONAVIRUS
TEST KITS OF SHENZHEN MICROPROFIT CURRENTLY IN DEVELOPMENT
    * CO ACTS AS EXCLUSIVE AGENT IN U.S. FOR 10 YRS FROM 2020

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS4hdPGH
Further company coverage:  1345.HK 

 ((Reuters.Briefs@thomsonreuters.com;))